These results were consistent with previous studies such as mangiferin, atractylenolide III, and puerarin reduced inflammatory responses by suppressing the NLRP3 inflammasome activation and cytokine expression, alleviated kidney damage [65,66,67]. Here, NLRP3 is linked to Nephropathy.